Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.

Suppr

超能文献

作者信息

Voigt W, Kegel T, Maher G, Jordan K, Müller L, Schmoll H-J

出版信息

Ann Oncol. 2006 Mar;17(3):531-3. doi: 10.1093/annonc/mdj028. Epub 2005 Oct 18.

DOI:10.1093/annonc/mdj028

PMID:16234294

Abstract

摘要

相似文献

Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer.

Ann Oncol. 2006 Mar;17(3):531-3. doi: 10.1093/annonc/mdj028. Epub 2005 Oct 18.

Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study.

Bone Marrow Transplant. 2010 Dec;45(12):1704-9. doi: 10.1038/bmt.2010.50. Epub 2010 Mar 15.

Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.

J Clin Oncol. 2007 Jan 1;25(1):85-90. doi: 10.1200/JCO.2006.06.9401.

Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.

Neurol Med Chir (Tokyo). 2013;53(11):779-85. doi: 10.2176/nmc.oa2013-0211. Epub 2013 Oct 21.

Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.

Cancer. 2013 Feb 1;119(3):665-71. doi: 10.1002/cncr.27783. Epub 2012 Sep 5.

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.

Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098.

High dose chemotherapy in germ cell tumors.

Tunis Med. 2005 Dec;83 Suppl 12:85-6.

Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.

Anticancer Drugs. 2006 Oct;17(9):1057-66. doi: 10.1097/01.cad.0000231469.46664.12.

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.

Ann Oncol. 2005 Jul;16(7):1152-9. doi: 10.1093/annonc/mdi228. Epub 2005 May 31.

Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial.

Oncol Res Treat. 2016;39(9):553-6. doi: 10.1159/000448868. Epub 2016 Sep 8.

引用本文的文献

High dose chemotherapy with stem cell support in the treatment of testicular cancer.

World J Stem Cells. 2015 Dec 26;7(11):1222-32. doi: 10.4252/wjsc.v7.i11.1222.

Emerging Therapeutic Targets for Male Germ Cell Tumors.

Curr Oncol Rep. 2015 Dec;17(12):54. doi: 10.1007/s11912-015-0479-4.

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.

Ann Oncol. 2015 Oct;26(10):2125-32. doi: 10.1093/annonc/mdv310. Epub 2015 Jul 21.

Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.

Braz J Med Biol Res. 2015 Jan;48(1):13-24. doi: 10.1590/1414-431x20144214. Epub 2014 Nov 4.

Gastroesphageal variceal hemorrhage induced by metastatic liver tumor of lung cancer.

Case Rep Oncol. 2012 Sep;5(3):644-50. doi: 10.1159/000345956. Epub 2012 Dec 6.

Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate.

Case Rep Oncol. 2009 Dec 11;2(3):234-241. doi: 10.1159/000260901.

Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.

Br J Cancer. 2010 Jun 29;103(1):18-28. doi: 10.1038/sj.bjc.6605725. Epub 2010 Jun 15.

Chemotherapy for patients with poor prognosis germ cell tumors.

World J Urol. 2009 Aug;27(4):471-6. doi: 10.1007/s00345-009-0404-2. Epub 2009 Mar 28.

GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.

Br J Cancer. 2007 Aug 6;97(3):308-14. doi: 10.1038/sj.bjc.6603865. Epub 2007 Jul 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验